Cargando…

Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India

INTRODUCTION: There is a scarcity of data from India on the impact of cell of origin (COO) on outcomes of diffuse large B-cell lymphoma (DLBCL). This study was conducted to evaluate the impact of COO on outcomes of DLBCL patients treated with uniform rituximab, cyclophosphamide, doxorubicin, vincris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gogia, Ajay, Nair, Sukesh, Arora, Shalabh, Kumar, Lalit, Sharma, Atul, Gupta, Ritu, Biswas, Ahitagni, Mallick, Saumyaranjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675100/ https://www.ncbi.nlm.nih.gov/pubmed/34926277 http://dx.doi.org/10.3389/fonc.2021.770747

Ejemplares similares

Ibrutinib-Induced Skin Rash
por: Kirar, Sudhir, et al.
Publicado: (2021)

Adult Burkitt lymphoma: An institutional experience with a uniform chemotherapy protocol
por: Patekar, Mukesh, et al.
Publicado: (2018)

Cutaneous T-cell lymphoma
por: Arora, Shalabh, et al.
Publicado: (2020)

Mantle Cell Lymphoma: A North Indian Tertiary Care Centre Experience
por: Das, Chandan Krushna, et al.
Publicado: (2016)

Diffuse large B-cell lymphoma: An institutional analysis
por: Gogia, Ajay, et al.
Publicado: (2018)

HIV-associated hematologic malignancies: Experience from a Tertiary Cancer Center in India
por: Reddy, Rakesh, et al.
Publicado: (2016)

Diffuse Large B-Cell Lymphoma Relapsing in Leukaemic Phase Presenting as Acute Leukaemia
por: Balasubramanian, Priyavadhana, et al.
Publicado: (2019)

Lymphomatoid Granulomatosis with Isolated Cutaneous Lesions: Prolonged Remission After DA-EPOCH Protocol
por: Gupta, Vineet Govinda, et al.
Publicado: (2018)

Diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia: A single center experience
por: Gogia, Ajay, et al.
Publicado: (2014)

Renal cell carcinoma concomitant with multiple myeloma
por: Narwal, Anubhav, et al.
Publicado: (2022)

Chronic lymphocytic leukemia with deletion 17p: An Indian scenario
por: Gogia, Ajay, et al.
Publicado: (2019)

Primary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical Sciences
por: Patekar, Mukesh, et al.
Publicado: (2019)

Clinical Response to CHOP vs. R-CHOP in Adult Patients with Diffuse Large B-Cell Lymphomas
por: Tariq, Ayesha, et al.
Publicado: (2018)

Chronic Lymphocytic Leukemia with Dermatomyositis: A Therapeutic Challenge
por: Kumar, Sudhir, et al.
Publicado: (2020)

Profile of non-Hodgkin lymphoma: An Indian perspective
por: Gogia, Ajay, et al.
Publicado: (2018)

Follicular lymphoma: an Institutional Analysis
por: Gogia, Ajay, et al.
Publicado: (2017)

Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma
por: Kumar, Lalit, et al.
Publicado: (2019)

Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy
por: Guo, Wei, et al.
Publicado: (2015)

Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
por: Terada, Yoshiki, et al.
Publicado: (2009)

Outcome of R-CHOP or CHOP Regimen for Germinal Center and Nongerminal Center Subtypes of Diffuse Large B-Cell Lymphoma of Chinese Patients
por: Huang, Ying, et al.
Publicado: (2012)

ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma
por: Nowakowski, Grzegorz S, et al.
Publicado: (2016)

Sciatic diffuse large B-cell lymphoma with treatment response to CHOP and radiotherapy
por: Shomal Zadeh, Firoozeh, et al.
Publicado: (2023)

RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome
por: Kaur, Gurvinder, et al.
Publicado: (2020)

Unusual Gastric Metastasis in Triple-Negative (Estrogen Receptor/Progesterone Receptor/HER2neu Negative) GATA-Binding Protein 3-Positive Breast Cancer
por: Baa, Annie Kanchan, et al.
Publicado: (2020)

Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14
por: Gutiérrez, Antonio, et al.
Publicado: (2015)

GM-CSF enhanced the effect of CHOP and R-CHOP on inhibiting diffuse large B-cell lymphoma progression via influencing the macrophage polarization
por: Zhang, Yu, et al.
Publicado: (2021)

Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis
por: Painschab, Matthew S, et al.
Publicado: (2021)

High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcome
por: Kumar, Lalit, et al.
Publicado: (2019)

Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia
por: Rani, Lata, et al.
Publicado: (2017)

Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma
por: Hu, Xin, et al.
Publicado: (2017)

R-CHOP resistance in diffuse large B-cell lymphoma: biological and molecular mechanisms
por: Wang, Liang, et al.
Publicado: (2021)

R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study
por: Kagami, Yoshitoyo, et al.
Publicado: (2020)

Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis
por: Hong, Junshik, et al.
Publicado: (2010)

Treatment results of radiotherapy following CHOP or R-CHOP in limited-stage head-and-neck diffuse large B-cell lymphoma: a single institutional experience
por: Jeong, Jae-Uk, et al.
Publicado: (2017)

P1216: ZANUBRUTINIB PLUS R-CHOP(RI-CHOP) AS THE TREATMENT FOR DOUBLE EXPRESSION OF MYC/BCL2 IN PATIENTS WITH DIFFUSED LARGE B-CELL LYMPHOMA
por: Ren, K., et al.
Publicado: (2022)

PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3)
por: Tessoulin, Benoit, et al.
Publicado: (2023)

R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma
por: Lee, Hong Ghi, et al.
Publicado: (2014)

Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
por: Kadota, Tomohiro, et al.
Publicado: (2019)

Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma
por: Choi, Soyeon, et al.
Publicado: (2022)

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s113klrkvu97oappt676plfbvi